Navid Ezra MD FAAD
Acne & Rosacea, Dermatologic Surgery
Board Certified Dermatologist
Join to View Full Profile
3095 Old Conejo RdSte 200Thousand Oaks, CA 91320
Phone+1 805-222-5803
Fax+1 805-222-0323
Dr. Ezra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Navid Ezra MD is a board certified dermatologist with offices in Ventura County, Los Angeles County, and Orange County.
Education & Training
Indiana University School of MedicineResidency, Dermatology, 2012 - 2015- Indiana University School of MedicineInternship, Internal Medicine, 2011 - 2012
David Geffen School of Medicine at UCLAClass of 2011
UCLABS, Psychobiology and Gerontology, 2006
Certifications & Licensure
CA State Medical License 2015 - 2026
HI State Medical License 2025 - 2026
NV State Medical License 2024 - 2025
OR State Medical License 2024 - 2025
American Board of Dermatology Dermatology
Clinical Trials
- Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) Start of enrollment: 2020 Jul 01
Roles: Contact
- Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2) Start of enrollment: 2020 Jul 01
Roles: Contact
- Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis Start of enrollment: 2022 Jun 30
Roles: Contact
Publications & Presentations
PubMed
- Autologous Cell Harvesting Device Provides Repigmentation and Improves Quality-of-Life for Patients with Stable Vitiligo Lesions in a Large and Diverse Patient Populat...Amit G Pandya, Bassel H Mahmoud, Richard H Huggins, Anand K Ganesan, Nanette B Silverberg
Journal of the American Academy of Dermatology. 2025-03-28 - 15 citationsA phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome.Raffaele Badolato, Laia Alsina, Antoine Azar, Yves Bertrand, Audrey A Bolyard
Blood. 2024-07-04 - Correction to: Dehydrated human amnion/chorion membrane allograft for postoperative wounds following Mohs micrographic surgery: a retrospective comparative evaluation.Sadaf Moradi, Ana Ormaza, Navid Ezra
Wounds. 2024-02-01
Other Languages
- Spanish, Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
